Fingerprint Screening Receives £3 Million Investment

Fingerprint Screening Receives £3 Million Investment

Intelligent Fingerprinting, a UK company developing a portable fingerprint-based drug screening system, has secured a further £3 million of funding from an expanded group of private US and UK investors. The investment will support the early commercialisation of the first drug screening panel and include manufacturing scale-up and validation of the company’s first products made at its dedicated facility in Cambridge. These products are to be used widely in pilot programmes within the UK and US.

Commenting on the investment, Intelligent Fingerprinting’s Chairman Philip Hand said: “2017 is set to be an important year for the business as we transition from running successful pilot projects to bringing our revolutionary technology to the broader market. The first product of its kind in the world, our mobile drug screening system is easy-to-use, non-invasive and works in minutes by analysing sweat from a fingerprint. This latest investment will enable the acceleration of activities across the business, including both our sales and marketing programmes as well as our ongoing FDA approval activities in the USA.”